Geode Capital Management, LLC Bio Affinity Technologies, Inc. Call Options Transaction History
Geode Capital Management, LLC
- $1.12 Trillion
- Q2 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding BIAF
# of Institutions
18Shares Held
400KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA172KShares$354,3070.0% of portfolio
-
Captrust Financial Advisors Raleigh, NC27.9KShares$57,4430.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny23KShares$47,3120.0% of portfolio
-
Ground Swell Capital, LLC Folly Beach, SC22.9KShares$47,0990.04% of portfolio
-
State Street Corp Boston, MA17.6KShares$36,2560.0% of portfolio
About bioAffinity Technologies, Inc.
- Ticker BIAF
- Exchange
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 2,727,580
- Market Cap $5.62M
- Description
- bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...